- Home
- EQR vs DXCM Comparison
EQR vs DXCM Comparison
Compare EQR & DXCM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EQR
- DXCM
- Stock Information
- Founded
- EQR 1993
- DXCM 1999
- Country
- EQR United States
- DXCM United States
- Employees
- EQR N/A
- DXCM N/A
- Industry
- EQR Real Estate Investment Trusts
- DXCM Medical/Dental Instruments
- Sector
- EQR Real Estate
- DXCM Health Care
- Exchange
- EQR Nasdaq
- DXCM Nasdaq
- Market Cap
- EQR 27.9B
- DXCM 28.0B
- IPO Year
- EQR 1993
- DXCM 2005
- Fundamental
- Price
- EQR $73.75
- DXCM $77.72
- Analyst Decision
- EQR Buy
- DXCM Buy
- Analyst Count
- EQR 19
- DXCM 17
- Target Price
- EQR $75.22
- DXCM $101.29
- AVG Volume (30 Days)
- EQR 1.4M
- DXCM 3.8M
- Earning Date
- EQR 01-28-2025
- DXCM 02-06-2025
- Dividend Yield
- EQR 3.66%
- DXCM N/A
- EPS Growth
- EQR 35.67
- DXCM 83.21
- EPS
- EQR 2.44
- DXCM 1.67
- Revenue
- EQR $2,940,829,000.00
- DXCM $3,954,000,000.00
- Revenue This Year
- EQR N/A
- DXCM $13.10
- Revenue Next Year
- EQR $4.01
- DXCM $14.79
- P/E Ratio
- EQR $30.26
- DXCM $46.61
- Revenue Growth
- EQR 3.33
- DXCM 16.19
- 52 Week Low
- EQR $57.33
- DXCM $62.34
- 52 Week High
- EQR $78.83
- DXCM $142.00
- Technical
- Relative Strength Index (RSI)
- EQR 46.72
- DXCM 56.89
- Support Level
- EQR $72.90
- DXCM $77.50
- Resistance Level
- EQR $78.32
- DXCM $82.26
- Average True Range (ATR)
- EQR 1.10
- DXCM 2.42
- MACD
- EQR -0.22
- DXCM 0.20
- Stochastic Oscillator
- EQR 15.68
- DXCM 53.44
About EQR Equity Residential of Beneficial Interest
Equity Residential owns a portfolio of 299 apartment communities with around 80,000 units and is developing three additional properties with 977 units. The company focuses on owning large, high-quality properties in the urban and suburban submarkets of Southern California, San Francisco, Washington, D.C., New York, Seattle, and Boston.
About DXCM DexCom Inc.
Dexcom designs and commercializes continuous glucose monitoring systems for diabetic patients. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is evolving its CGM systems to provide integration with insulin pumps from Insulet and Tandem for automatic insulin delivery.